Sickle-cell disease causes: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:


{{Shyam}}
{{Shyam}}
{{AG}}


==References==
==References==

Revision as of 01:57, 30 June 2016

Sickle-cell disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sickle-cell disease from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Sickle-cell disease causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sickle-cell disease causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Sickle-cell disease causes

CDC on Sickle-cell disease causes

Sickle-cell disease causes in the news

Blogs onSickle-cell disease causes

Directions to Hospitals Treating Sickle-cell disease

Risk calculators and risk factors for Sickle-cell disease causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

Causes

The cause of sickle cell disease is based on a point mutation at the 6th position of the beta-globin chain of hemoglobin. The genetic mutation that occurs in the HBB gene results in replacement of glutamic acid for valine.[1] This amino acid substitution results in increased hydrophobic interactions, causing a sickled shape of red blood cells.[2]

Shyam Patel [2]

References

  1. Saraf SL, Molokie RE, Nouraie M, Sable CA, Luchtman-Jones L, Ensing GJ; et al. (2014). "Differences in the clinical and genotypic presentation of sickle cell disease around the world". Paediatr Respir Rev. 15 (1): 4–12. doi:10.1016/j.prrv.2013.11.003. PMC 3944316. PMID 24361300.
  2. Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I; et al. (2012). "Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management". ScientificWorldJournal. 2012: 949535. doi:10.1100/2012/949535. PMC 3415156. PMID 22924029.

Template:WH Template:WS